C. Ann Merrifield, Director at INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV), bought 2,000 shares at $12.36 ($25K) on 2015-08-12, disclosed to the SEC on 2015-08-14.
Open-market purchase of $25k NVIV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LYRA | BUY | 2021-06-22 | $31K | — | Filing → |
| FLXN | BUY | 2019-05-24 | $101K | — | Filing → |
| JNP | BUY | 2016-08-29 | $11K | — | Filing → |